Burbach Gerhard F 4
4 · Sight Sciences, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) Director Gerhard Burbach Receives RSU Award
What Happened
Gerhard F. Burbach, a member of the Sight Sciences (SGHT) board of directors, was granted 28,261 restricted stock units (RSUs) on June 4, 2026. The award is reported as an acquisition at $0.00 per share (no cash paid); the grant value is approximately $130,000 based on the closing price on the grant date. The RSUs vest on the earlier of June 4, 2027 or the Company’s 2027 annual meeting, subject to his continued service as a director.
Key Details
- Transaction date: 2026-06-04 (report filed 2026-06-05). Transaction code: A (award/grant).
- Shares/units granted: 28,261 RSUs; reported acquisition price: $0.00 (cash value reported = $0). Estimated grant value ≈ $130,000 per footnote.
- Shares/ownership after transaction (per filing): 44,922 shares of common stock, 28,261 RSUs newly granted, and 49,844 previously granted RSUs — totaling rights to 123,027 share equivalents (includes unvested RSUs).
- Vesting: RSUs vest on the earlier of 6/4/2027 or the 2027 annual meeting, contingent on continued board service. (See footnote F1 and F2 in the filing.)
- Timeliness: Filing appears timely (reported the next business day).
Context
RSUs are a form of equity compensation that convert to common shares upon vesting; no shares were sold or purchased on the open market. Such awards are routine for non-employee directors and reflect compensation rather than immediate trading activity.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-04+28,261→ 123,207 total
Footnotes (2)
- [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
- [F2]Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported.